Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.08. | Retractable Technologies reports Q2 results | 2 | Seeking Alpha | ||
14.08. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | 1 | SEC Filings | ||
14.08. | RETRACTABLE TECHNOLOGIES INC - 10-Q, Quarterly Report | - | SEC Filings | ||
23.07. | Retractable Technologies cuts workforce by 12.4% amid tariff pressures | 1 | Investing.com | ||
23.07. | Retractable Technologies streicht wegen Zolldrucks 12,4 % der Stellen | 2 | Investing.com Deutsch | ||
23.07. | Retractable Technologies reduces workforce by 12.4% | 1 | Seeking Alpha | ||
23.07. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | 2 | SEC Filings | ||
RETRACTABLE TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
01.07. | Retractable Technologies declares $1.00 dividend | 1 | Seeking Alpha | ||
30.06. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | 1 | SEC Filings | ||
06.06. | Retractable Technologies ernennt nach Fusion neuen Wirtschaftsprüfer | 1 | Investing.com Deutsch | ||
06.06. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | - | SEC Filings | ||
15.05. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | 4 | SEC Filings | ||
15.05. | RETRACTABLE TECHNOLOGIES INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
11.04. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | 2 | SEC Filings | ||
11.04. | Retractable Technologies cuts workforce to reduce reliance on China amid trade war | 1 | MassDevice | ||
10.04. | Retractable Technologies reduces workforce by about 7% | 1 | Seeking Alpha | ||
31.03. | Retractable Technologies declares $1.00 dividend | 3 | Seeking Alpha | ||
28.03. | Retractable Technologies reports FY results | 1 | Seeking Alpha | ||
28.03. | RETRACTABLE TECHNOLOGIES INC - 8-K, Current Report | 1 | SEC Filings | ||
28.03. | RETRACTABLE TECHNOLOGIES INC - 10-K, Annual Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ROKU | 80,42 | -0,91 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 05.09.2025 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
BICO GROUP | 2,174 | -0,18 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,112 | -0,88 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
ATOSSA THERAPEUTICS | 0,680 | -0,44 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
PING AN HEALTHCARE | 2,516 | +1,49 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,260 | -0,76 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
VERU | 3,820 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
CYTOSORBENTS | 0,853 | +5,96 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,631 | 0,00 % | H.C. Wainwright bestätigt Kaufempfehlung für VolitionRX nach Partnerschaft mit Werfen | ||
EKSO BIONICS | 4,070 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 4,900 | +2,51 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 48,280 | +2,20 % | Siemens Healthineers: Die Langeweile setzt sich fort! | ||
FRESENIUS MEDICAL CARE | 42,380 | -1,10 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen |